Oncoclinicas do Brasil Srvcs Mdcs SA (ONCO3) Stock Price & News

ONCO3:BVMF

Oncoclinicas do Brasil Srvcs Mdcs SA

R$0.77

+5.48%

(+0.040) 1D

Nov 4, 6:04:00 PM GMT-3 · BRL

All symbols

	Symbol	Price	Change	% Change

Next call in 13 days

Tue, Nov 17, 3:00 PM

Fiscal period

Q3 2026

- /

Revenue / Est. (BRL)

- / 1.31B

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in BRL

Loading Previous Earnings...

All values in BRL	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.41B	1.37B	1.16B	1.05B
Cost of goods sold	959.85M	887.92M	961.32M	818.44M
Cost of revenue	959.85M	887.92M	961.32M	818.44M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	283.58M	366.58M	313.07M	315.35M
Operating expense	1.89B	514.52M	481.09M	519.42M
Total operating expenses	2.85B	1.40B	1.44B	1.34B
Operating income	-1.43B	-33.61M	-281.64M	-290.11M
Other non operating income	-9.60M	-568.93M	-91.29M	-4.84M
EBT including unusual items	-1.85B	-1.09B	-496.74M	-483.15M
EBT excluding unusual items	-1.63B	-606.65M	-493.21M	-479.97M
Income tax expense	26.67M	429.22M	2.56M	-7.42M
Effective tax rate	-1.44%	-39.49%	-0.51%	1.53%
Other operating expenses	1.60B	147.94M	168.02M	204.07M
Net income	-1.88B	-1.45B	-424.85M	-468.99M
Net profit margin	-133.22%	-106.22%	-36.60%	-44.76%
Earnings per share	-0.15	-0.34	-0.40	-0.72
Interest and investment income	44.65M	1.45M	5.37M	2.76M
Interest expense	-230.76M	-6.99M	-131.22M	-163.83M
Net interest expenses	-186.11M	-5.54M	-125.85M	-161.07M
Depreciation and amortization charges	-	-	-	-
EBITDA	-1.39B	13.39M	-241.09M	-253.64M
Gain or loss from assets sale	466.21M	-31.88M	-11.81M	11.81M

Finance